Celsius Holdings, Inc. (NASDAQ:CELH) Shares Sold by Guggenheim Capital LLC

Guggenheim Capital LLC cut its position in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 54.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,500 shares of the company's stock after selling 16,106 shares during the period. Guggenheim Capital LLC's holdings in Celsius were worth $356,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of the company. HM Payson & Co. boosted its stake in Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after purchasing an additional 550 shares during the period. S.A. Mason LLC boosted its position in shares of Celsius by 100.0% during the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock worth $37,000 after acquiring an additional 700 shares during the last quarter. GAMMA Investing LLC increased its holdings in Celsius by 185.7% in the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock valued at $45,000 after acquiring an additional 1,114 shares during the last quarter. Blue Trust Inc. lifted its stake in Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock worth $47,000 after purchasing an additional 441 shares in the last quarter. Finally, Knuff & Co LLC bought a new position in shares of Celsius during the 4th quarter valued at about $50,000. 60.95% of the stock is currently owned by institutional investors.

Celsius Price Performance

Celsius stock traded up $0.08 during trading hours on Thursday, reaching $35.04. The stock had a trading volume of 2,758,792 shares, compared to its average volume of 7,799,518. Celsius Holdings, Inc. has a 52 week low of $21.10 and a 52 week high of $98.85. The company has a market cap of $9.03 billion, a price-to-earnings ratio of 79.65, a PEG ratio of 2.90 and a beta of 1.58. The business's 50 day moving average price is $32.84 and its 200-day moving average price is $29.58.

Celsius (NASDAQ:CELH - Get Free Report) last announced its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.03. The company had revenue of $332.20 million during the quarter, compared to the consensus estimate of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. On average, sell-side analysts forecast that Celsius Holdings, Inc. will post 0.89 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the sale, the director now directly owns 19,106 shares in the company, valued at $543,947.82. This trade represents a 17.31 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the transaction, the insider now owns 45,297 shares in the company, valued at $1,167,303.69. The trade was a 18.36 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on CELH shares. Roth Mkm reissued a "buy" rating and issued a $38.00 target price on shares of Celsius in a report on Friday, February 21st. Truist Financial upgraded shares of Celsius from a "hold" rating to a "buy" rating and raised their target price for the stock from $35.00 to $45.00 in a report on Monday, March 31st. B. Riley reaffirmed a "buy" rating and issued a $49.00 price target (up previously from $44.00) on shares of Celsius in a research note on Friday, February 21st. Piper Sandler boosted their price objective on shares of Celsius from $43.00 to $44.00 and gave the company an "overweight" rating in a research report on Thursday, April 17th. Finally, LADENBURG THALM/SH SH reduced their target price on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. One research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $46.47.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.